Creating a novel population of mutant tissues helps scientists deduce the cause of polycystic kidney disease and other cilia-linked illnesses.
National Institute of Health’s Mendelian Genomics Research Consortium unites five leading genomic sciences centers.
Case in point: A drug for cancer was found to extend lives of people with progeria, and may have broader use in cardiovascular health.
